<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">445854022</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180317145422.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170323e20110201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s00204-010-0564-2</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s00204-010-0564-2</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Marine brevetoxin induces IgE-independent mast cell activation</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Susana Hilderbrand, Rachel Murrell, James Gibson, Jared Brown]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Brevetoxins (PbTx) are sodium channel neurotoxins produced by the marine dinoflagellate Karenia brevis during red tide blooms. Inhalation of PbTx in normal individuals and individuals with pre-existing airways disease results in adverse airway symptoms including bronchoconstriction. In animal models of allergic inflammation, inhalation of PbTx results in a histamine H1-mediated bronchoconstriction suggestive of mast cell activation. How mast cells would respond directly to PbTx is unknown. We thus explored the activation of mouse bone marrow-derived mast cells (BMMCs) following exposure to purified PbTx-2. Following in vitro exposure to PbTx-2, we examined cellular viability, mast cell degranulation (β-hexosaminidase release), intracellular Ca2+ and Na+ flux, and the production of inflammatory mediators (IL-6). PbTx-2 induced significant cellular toxicity within 24h as measured by LDH release and Annexin-V staining. However, within 1h of exposure, PbTx-2 induced BMMC degranulation and an increase in IL-6 mRNA expression independent of the high-affinity IgE receptor (FcεRI) stimulation. Activation of BMMCs by PbTx-2 was associated with altered intracellular Ca2+ and Na+ levels. Brevenal, a naturally produced compound that antagonizes the activity of PbTx, prevented changes in intracellular Na+ levels but did not alter activation of BMMCs by PbTx-2. These findings demonstrate that PbTx-2 activates mast cells independent of FcεRI providing insight into critical events in the pathogenesis and a potential therapeutic target in brevetoxin-induced airway symptoms.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer-Verlag, 2010</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Brevetoxin</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Mast cell</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Immune</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Hilderbrand</subfield>
   <subfield code="D">Susana</subfield>
   <subfield code="u">Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Medical Sciences Building, 6W-33, 600 Moye Blvd, 27834, Greenville, NC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Murrell</subfield>
   <subfield code="D">Rachel</subfield>
   <subfield code="u">Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Medical Sciences Building, 6W-33, 600 Moye Blvd, 27834, Greenville, NC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Gibson</subfield>
   <subfield code="D">James</subfield>
   <subfield code="u">Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Medical Sciences Building, 6W-33, 600 Moye Blvd, 27834, Greenville, NC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Brown</subfield>
   <subfield code="D">Jared</subfield>
   <subfield code="u">Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Medical Sciences Building, 6W-33, 600 Moye Blvd, 27834, Greenville, NC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Archives of Toxicology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">85/2(2011-02-01), 135-141</subfield>
   <subfield code="x">0340-5761</subfield>
   <subfield code="q">85:2&lt;135</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">85</subfield>
   <subfield code="o">204</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s00204-010-0564-2</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s00204-010-0564-2</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Hilderbrand</subfield>
   <subfield code="D">Susana</subfield>
   <subfield code="u">Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Medical Sciences Building, 6W-33, 600 Moye Blvd, 27834, Greenville, NC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Murrell</subfield>
   <subfield code="D">Rachel</subfield>
   <subfield code="u">Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Medical Sciences Building, 6W-33, 600 Moye Blvd, 27834, Greenville, NC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Gibson</subfield>
   <subfield code="D">James</subfield>
   <subfield code="u">Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Medical Sciences Building, 6W-33, 600 Moye Blvd, 27834, Greenville, NC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Brown</subfield>
   <subfield code="D">Jared</subfield>
   <subfield code="u">Department of Pharmacology and Toxicology, Brody School of Medicine, East Carolina University, Medical Sciences Building, 6W-33, 600 Moye Blvd, 27834, Greenville, NC, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Archives of Toxicology</subfield>
   <subfield code="d">Springer-Verlag</subfield>
   <subfield code="g">85/2(2011-02-01), 135-141</subfield>
   <subfield code="x">0340-5761</subfield>
   <subfield code="q">85:2&lt;135</subfield>
   <subfield code="1">2011</subfield>
   <subfield code="2">85</subfield>
   <subfield code="o">204</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
